Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UBE2Q2 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Ube2q2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2Q2 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | decreases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of UBE2Q2 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | affects expression | ISO | Ube2q2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of UBE2Q2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of UBE2Q2 mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of UBE2Q2 mRNA | CTD | PMID:30851411 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23146750 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Ube2q2 (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of UBE2Q2 mRNA | CTD | PMID:19162173 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Ube2q2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of UBE2Q2 mRNA | CTD | PMID:36041667 | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | affects abundance | EXP | | 6480464 | UBE2Q2 gene SNP affects the abundance of Uric Acid | CTD | PMID:23263486 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of UBE2Q2 protein | CTD | PMID:20106945 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of UBE2Q2 mRNA | CTD | PMID:33167477 | antimycin A | decreases expression | EXP | | 6480464 | Antimycin A results in decreased expression of UBE2Q2 mRNA | CTD | PMID:33512557 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of UBE2Q2 mRNA | CTD | PMID:33212167 | Aroclor 1254 | decreases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of UBE2Q2 mRNA | CTD | PMID:23650126 | benzo[a]pyrene | decreases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of UBE2Q2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of UBE2Q2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of UBE2Q2 mRNA | CTD | PMID:33221593 | bisphenol A | multiple interactions | ISO | Ube2q2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of UBE2Q2 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | Ube2q2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of UBE2Q2 mRNA | CTD | PMID:34947998 | bisphenol F | multiple interactions | ISO | Ube2q2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of UBE2Q2 mRNA | CTD | PMID:36041667 | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBE2Q2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBE2Q2 mRNA | CTD | PMID:35301059 | crocidolite asbestos | increases methylation | EXP | | 6480464 | Asbestos and Crocidolite results in increased methylation of UBE2Q2 promoter | CTD | PMID:29626692 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of UBE2Q2 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBE2Q2 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of UBE2Q2 mRNA | CTD | PMID:29803840 | ethanol | multiple interactions | ISO | Ube2q2 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of UBE2Q2 mRNA | CTD | PMID:30319688 | fenofibrate | multiple interactions | ISO | Ube2q2 (Mus musculus) | 6480464 | PPARA protein affects the reaction [Fenofibrate results in increased expression of UBE2Q2 mRNA] | CTD | PMID:21318169 | fenofibrate | increases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Fenofibrate results in increased expression of UBE2Q2 mRNA | CTD | PMID:21318169 | fenpyroximate | decreases expression | EXP | | 6480464 | fenpyroximate results in decreased expression of UBE2Q2 mRNA | CTD | PMID:33512557 | fenthion | decreases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of UBE2Q2 mRNA | CTD | PMID:34813904 | flutamide | increases expression | ISO | Ube2q2 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of UBE2Q2 mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of UBE2Q2 mRNA | CTD | PMID:25629700 | inulin | multiple interactions | ISO | Ube2q2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of UBE2Q2 mRNA | CTD | PMID:36331819 | lead(0) | affects splicing | EXP | | 6480464 | Lead affects the splicing of UBE2Q2 mRNA | CTD | PMID:28903495 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of UBE2Q2 mRNA | CTD | PMID:28988120 | nefazodone | increases expression | ISO | Ube2q2 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of UBE2Q2 mRNA | CTD | PMID:24136188 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ube2q2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2Q2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of UBE2Q2 mRNA | CTD | PMID:36331819 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of UBE2Q2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBE2Q2 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of UBE2Q2 mRNA | CTD | PMID:19710929 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of UBE2Q2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UBE2Q2 mRNA | CTD | PMID:22079256 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of UBE2Q2 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of UBE2Q2 mRNA | CTD | PMID:30851411 | rotenone | decreases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Rotenone results in decreased expression of UBE2Q2 mRNA | CTD | PMID:23186747 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBE2Q2 mRNA | CTD | PMID:27188386 | sevoflurane | increases methylation | ISO | Ube2q2 (Mus musculus) | 6480464 | Sevoflurane results in increased methylation of UBE2Q2 mRNA | CTD | PMID:35249202 | sodium arsenate | increases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of UBE2Q2 mRNA | CTD | PMID:21795629 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of UBE2Q2 mRNA | CTD | PMID:34032870 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of UBE2Q2 mRNA | CTD | PMID:31533062 | tebufenpyrad | decreases expression | EXP | | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of UBE2Q2 mRNA | CTD | PMID:33512557 | tetrachloromethane | increases expression | ISO | Ube2q2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of UBE2Q2 mRNA | CTD | PMID:31919559 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of UBE2Q2 mRNA | CTD | PMID:24935251 and PMID:26272509 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of UBE2Q2 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of UBE2Q2 mRNA | CTD | PMID:29154799 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of UBE2Q2 gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of UBE2Q2 mRNA | CTD | PMID:25979313 | |